However, the intensity of CX3CR1-IF was increased bilaterally in glial-like cells of the TSC following both IONL and sham operations at all examined survival times (Figure 4B–Q, insets), except in the TSC contralateral to the IONL or sham operation at POD1 (Figure 4C,E). The gene discussed is CX3CR1; the disease is tuberous sclerosis.